Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 30, 2005American Journal of Clinical Oncology

Phase II Study of Low-Dose Docetaxel/Fluorouracil/Cisplatin in Metastatic Gastric Carcinoma

View Full Paper
Ask AI
Bookmark
Share

Authors

SPSook Ryun ParkSeoul Medical CenterJCJong Ho ChunJohns Hopkins UniversityYKYoung‐Woo KimSeoul National University Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Park et al. (2005) studied this question.

synapsesocial.com/papers/6a9ff8af645fa8fa55ef7391https://doi.org/10.1097/01.coc.0000162424.69631.79
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Reporting results of cancer treatment1981 · 7,867 citations
  2. 2FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer.1992 · 292 citations
  3. 3Phase II Trial of the Combination of Paclitaxel and 5-Fluorouracil in the Treatment of Advanced Gastric Cancer1999 · 86 citations
  4. 4Randomized Phase III Trial of Fluorouracil Alone Versus Fluorouracil Plus Cisplatin Versus Uracil and Tegafur Plus Mitomycin in Patients With Unresectable, Advanced Gastric Cancer: The Japan Clinical Oncology Group Study (JCOG9205)2002 · 431 citations